Reply  by Price, Matthew J. & Teirstein, Paul S.
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October 17, 2006:1727–30igh rate of major adverse cardiac events (MACE) (10% in-
ospital, 44% at 1 year). The study, however, presented several
mportant limitations, as already outlined by the investigators
hemselves (1), and in the accompanying editorial (2). We would
ike to comment on several other important issues.
In recent years interventional cardiologists have been trying to
efine the best strategy for bifurcation coronary stenting
provisional-T, V-stenting, or simultaneous kissing stent [SKS],
rush, culotte). Contemporary published data suggest that in case
f a small diameter side branch (SB), stenting of the main vessel
ith simple balloon angioplasty of the SB with provisional stenting
“only if needed”) seems to be associated with the best overall
ong-term outcome (3). The crush technique seems to have a
umber of disadvantages in cases of true bifurcation lesions with
mall SB, because the resulting 3 metal layers in the SB-ostium
end to increase the risk of restenosis (ISR) (4). It is therefore
ossible that the excess of ISR of the left circumflex ostium
bserved in the Price et al. (1) series was mainly related to the
articular adopted stenting strategy.
In our view, this high target lesion revascularization (TLR) rate
hould be interpreted cautiously. The majority of other investiga-
ors recently reported similar series showing encouraging TLR and
ACE rates at 6 and 12 months, clearly contrasting with the
esults of the Price et al. study (5–8).
In addition, we would propose not to be overly concerned by the
levated 1-year MACE rate (TLR: 38%) reported by Price et al.
1), but to pay more attention to some pharmacological and
natomical aspects enumerated below:
. The importance of the clopidogrel loading dose in such a
delicate procedure (the same patient without the loading dose
experienced 3 of the 5 in-hospital MACE).
. The ULMCA stenting strategy should be tailored to the
specific coronary anatomy (SKS or V-stenting in case of ostial
involvement of both major vessels; provisional-T stenting if
one of the ostia remains disease free).
Finally, in our opinion, percutaneous coronary intervention for
LMCA disease is progressively becoming a worldwide standard
f care; therefore, interventional cardiologists should make an
ffort to generate strong evidence supporting safety and long-term
fficacy of this very promising technique, utilizing data generated
rom tailored stented ULMCA with carefully performed clinical
nd angiographic follow-up protocols (1,5–8).
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EPLY
e appreciate the comments by Dr. Bonvini et al. regarding our
tudy (1). Their concerns appropriately highlight the difficulty in
efining the best strategy for approaching stent implantation
ithin the distal bifurcation of the unprotected left main coronary
rtery (ULMCA). The investigators believe our “elevated” rate of
ajor adverse cardiac events (MACE) could be due to use of the
crush” technique. In our study, the majority of patients (68%)
ere treated with simultaneous kissing stents (SKS), whereas only
small minority of patients (16%) underwent “crush” stenting.
herefore, our higher than expected MACE rate (44% at 9
onths) cannot be explained by the use of the “crush” technique
lone. We believe our increased late revascularization rate, com-
ared to other series, was likely due to our unusually high (98%)
ate of angiographic follow-up and the presence of distal left main
isease (DLMD) in nearly all (94%) of our patients.
Interestingly, a very recent report describing late follow-up after
MCA intervention with drug-eluting stents (DES) documented
utcomes similar to our report. In that study (2), the cumulative
ncidence of MACE was 30% in patients with DLMD; in those at
igh surgical risk (similar to two-thirds of the patients in our
tudy), the risk of MACE was 40%. Importantly, stenting
echnique (bifurcation versus main branch only) had no impact on
utcomes. It is difficult, however, to draw conclusions about the
ppropriate stent technique from any of the published data about
ES for ULMCA because the choice of technique in these studies
s operator-driven, presumably in response to specific lesion
haracteristics (angulation of the distal bifurcation, diameter and
egree of stenosis within the left circumflex, etc.).
We do agree with Dr. Bonvini et al. that a meticulous technical
pproach to ULMCA stenting is essential. We continue to use
ES to treat many patients with ULMCA disease. We have now
hanged our technique (based on our reported experience) in the
ollowing manner: 1) we always preload patients with 300 to 600
g of clopidogrel; 2) we always complete the stent implantation
rocedure with a high-pressure postdilation using noncompliant
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October 17, 2006:1727–30alloons; 3) we always employ postprocedure intravascular ultra-
ound to confirm stent expansion and apposition; and 4) we
outinely use glycoprotein IIb/IIIa inhibitors in the absence of
ignificant bleeding risk.
Finally, before percutaneous coronary intervention for unpro-
ected LMCA disease becomes the “worldwide standard of care,”
t is imperative that further studies define the optimal stenting
trategy based on specific lesion characteristics and also determine
hether restenosis of the left circumflex ostium has a benign
rognosis if left untreated. This truth is self-evident: all left main
esions are not alike, and they should not be treated as equals.
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an Technical
imitations of Strain Rate Imaging
e Overtaken by Particular Arrangements?
he present letter concerns the State-of-the-Art Paper by Mar-
ick (1) published in the April 4, 2006, issue of the Journal. The
linical impact of this report is valuable because the potentiality of
oppler echocardiographically-derived strain rate imaging (SRI) is
ften emhpasized, whereas the technical limitations are not always
hown. The illustrations, derived from a reference group for this
ethodology, clearly demonstrate sources of pitfalls and misinter-
retations due to either wrong recording or measure of SRI.
In our experience, at least 2 of these technical limitations may be
vertaken or blunted by arrangements performed during imaging
ecording and/or off-line measures. First, the noisy signal of SRI
especially of strain rate) can be drastically reduced by very high
rame rates of color tissue Doppler recording. Modern machines
re certainly able to provide frame rates 100 frames/s. However,
he highest frame rates are obtained with the narrowest scan of a
iven, isolated wall. By this modality, frame rates 250 frames/s
even 300 frames/s in the last-generation equipment) can be
chieved, with consequent optimization of both strain and strain-
ate measure. The obvious price to pay for this operation is the loss
f visualization of the overall ventricle and the consequent need to
eparately assess the various left ventricular (LV) walls. In the pbsence of regional wall motion abnormalities and/or focal cardiac
athologies, the wall with the best imaging quality (e.g., posterior
eptum or inferior wall) may be chosen as a reference region of
nterest. The consequent quantitative information may be extrap-
lated to the overall myocardium, both at rest and during phar-
acological response to dobutamine, to assess the functional state
nd the inotropic reserve, respectively.
In addition, the possible inappropriate timing of the different
hases of the cardiac cycle may be overtaken. The application of
RI implies per se a correct identification of systolic and diastolic
ime intervals. This aspect is crucial for the assessment of myocar-
ial dyssynchrony, when a postsystolic motion, occurring during a
rolonged relaxation time, might be confused with the normal
ystolic contraction. This may be avoided by marking end-diastole
nd end-systole on previously recorded pulsed Doppler imaging of
itral inflow and LV output flow, respectively. In the last-
eneration machines, by using this method, markers of mitral valve
pening and closure as well as markers of aortic valve opening and
losure are automatically superimposed to SRI (2). Alternatively,
ystolic and diastolic time intervals can be identified by the method
roposed by Voigt et al. (3): LV end-systole (i.e., the aortic valve
losure) is derived by color tissue Doppler superimposed to
-mode, as the end-systolic thin blue line, which, caused by a
rief backward motion of the mitral valve secondary to aortic valve
losure, is visualized within the otherwise red-colored mitral
nterior leaflet. This method is, however, complex and difficult to
pply in the clinical setting.
Nowadays, SRI remains a tool useful for research purposes more
han for clinical application. Nevertheless, some information about
efinements and arrangements during recording and reading of the
xamination may lead to a more appropriate use of this tool.
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e appreciate the interest and commentary of Dr. Galderisi
oncerning my report (1). His suggestions may help with the
voidance of artifact, but they may not be sufficient to make this
echnique a standard clinical tool. Narrow sector imaging certainly
ermits acquisition at a high frame rate, while maintaining a high
